Pittsburgh, PA, United States of America

Anthony J Kanai

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Anthony J Kanai

Introduction

Anthony J Kanai is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of mitochondrial research, holding a total of 3 patents. His work focuses on developing innovative methods for delivering therapeutic agents to mitochondria, which play a crucial role in cellular health.

Latest Patents

One of his latest patents is centered around selective targeting agents for mitochondria. This invention provides a composition and related methods for delivering cargo to mitochondria, which includes a membrane-active peptidyl fragment that has a high affinity for mitochondria and the desired cargo. The cargo can be selected from a wide variety of substances intended for specific therapeutic purposes. The patent discusses compositions and methods for treating illnesses associated with cellular damage or dysfunction due to excessive mitochondrial production of reactive oxygen species (ROS). By utilizing structural signaling recognizable by cells as mitochondrial targeting sequences, these compositions act as mitochondria-selective targeting agents. The invention aims to inhibit cell death by apoptosis through ROS-scavenging activity, thereby increasing patient survival rates.

Career Highlights

Anthony J Kanai is affiliated with the University of Pittsburgh, where he continues to advance his research in mitochondrial targeting and therapeutic delivery systems. His innovative work has garnered attention in the scientific community, contributing to the understanding of mitochondrial function and its implications for health.

Collaborations

Some of his notable coworkers include Peter Wipf and Jingbo Xiao, who have collaborated with him on various research projects related to mitochondrial therapies.

Conclusion

Anthony J Kanai's contributions to mitochondrial research and his innovative patents highlight the importance of targeted therapies in treating cellular dysfunction. His work continues to pave the way for advancements in medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…